A new model is unlocking global innovation for companies ready to grow – without going it alone.

Global Capability Centers (GCCs) have become a strategic force in life sciences, supporting innovation, efficiency, and resilience. While traditionally accessible only to large enterprises, a new approach is making GCCs viable for mid-size MedTech firms. This report looks at fractional models, and the strategic edge they create.

The shift to GCCs is backed by compelling data:

  • 20% annual cost decline after year three
  • 3.2x more digital patents per $1M investment vs. outsourced models
  • 93% of GCC leaders report directly to the C-suite (vs. 29% in outsourcing)

Now, the fractional GCC offers mid-size companies a way to tap into the benefits, without the prohibitive costs. To learn more about this model, and whether it’s right for your organisation, read our full report.

Download now